Acute Promyelocytic Leukemia Study
SWOG S0521: A Randomized Trial of Maintenance Versus Observation for Patients with previously Untreated Low and Intermediated Risk Acute Promyelocytic Leukemia (APL), Phase III
Protocol ID
08-061
Protocol Description
The purpose of this study is to learn about the effects of treating acute promyelocytic leukemia (APL) with chemotherapy. One of the main experimental purposes of this study is to study the effects, good and/or bad, of maintenance therapy, compared to no further treatment.
Eligibility Criteria
Patients with low or intermediate risk acute promyelocytic leukemia (APL) that has never been treated
Primary Investigator(s)
- Jonathan Kolitz, MD